Celsion - 22 Year Stock Price History | CLSN

Historical daily share price chart and data for Celsion since 1999 adjusted for splits. The latest closing stock price for Celsion as of October 15, 2021 is 1.00.
  • The all-time high Celsion stock closing price was 8826.30 on March 02, 2000.
  • The Celsion 52-week high stock price is 3.48, which is 248% above the current share price.
  • The Celsion 52-week low stock price is 0.43, which is 57% below the current share price.
  • The average Celsion stock price for the last 52 weeks is 1.16.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Celsion Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2021 1.3021 0.8031 2.8100 0.7915 1.0000 40.65%
2020 1.3472 1.7300 5.2600 0.4720 0.7110 -58.42%
2019 1.8717 1.6700 2.4700 1.0801 1.7100 21.28%
2018 2.4829 2.8200 3.3200 1.3600 1.4100 -47.39%
2017 3.0280 4.4118 7.1429 1.2800 2.6800 -37.03%
2016 17.1710 27.0308 27.0308 4.2563 4.2563 -84.17%
2015 32.1009 33.4734 44.1176 23.1092 26.8908 -17.60%
2014 44.6184 56.8627 64.0056 32.0728 32.6331 -40.10%
2013 104.5111 522.5312 589.3446 48.2191 54.4818 -89.45%
2012 224.9077 108.4142 556.5683 103.3717 516.2281 381.76%
2011 177.5145 138.6693 266.6233 106.5233 107.1536 -17.07%
2010 213.9821 195.4040 342.8914 126.6933 129.2146 -37.31%
2009 214.6009 174.5973 326.5032 129.2146 206.1130 48.64%
2008 252.0075 204.8524 409.7048 126.0630 138.6693 -25.93%
2007 301.7050 152.5363 447.5237 147.4937 187.2036 56.32%
2006 203.7777 255.1501 367.4737 113.4567 119.7599 -53.06%
2005 354.4501 510.3001 548.1001 245.7001 255.1501 -52.63%
2004 809.3627 1200.1503 1719.9004 387.4501 538.6501 -56.49%
2003 779.2502 387.4501 1417.5003 378.0001 1237.9503 204.65%
2002 478.6501 699.3001 926.1002 321.3001 406.3501 -34.85%
2001 851.1098 1124.5502 2475.9005 387.4501 623.7001 -34.00%
2000 3184.0132 2835.0006 8826.3019 945.0002 945.0002 -65.99%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.087B $0.001B
Celsion is dedicated to the development and commercialization of oncology drugs including tumor-targeting treatments using focused heat energy in combination with heat activated drug delivery systems. Celsion has research, license or commercialization agreements with leading institutions such as the National Institutes of Health, Duke University Medical Center, University of Hong Kong, North Shore Long Island Jewish Health System.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $129.683B 8.63
Bio-Rad Laboratories (BIO.B) United States $21.975B 46.83
QIAGEN (QGEN) Netherlands $11.773B 19.94
Biohaven Pharmaceutical Holding (BHVN) United States $8.738B 0.00
Emergent Biosolutions (EBS) United States $2.722B 6.57
Arcus Biosciences (RCUS) United States $2.455B 0.00
Myovant Sciences (MYOV) United Kingdom $1.915B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.755B 0.00
Zymeworks (ZYME) Canada $1.208B 0.00
Ambrx Biopharma (AMAM) United States $0.470B 0.00
SQZ Biotechnologies (SQZ) United States $0.342B 0.00
Enzo Biochem (ENZ) United States $0.183B 18.00